Sydney, Nov 3, 2017 AEST (ABN Newswire) - Anatara Lifesciences (ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's (TRI) Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality". Through her presentation, Tracey shared her personal journey - translating core research about pineapple roots and piglet gut health - to her current status as CSO of a publicly listed company, which is intent on changing the livestock industry globally.

To read more, please visit:

About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see for further background.



Investor inquiries:
Dr Mel Bridges
Chairman & CEO
Anatara Lifesciences
Phone: +61-413-051-600

Media inquiries:
Jane Lowe
IR Department
Phone: +61-411-117-774

Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 53) (Last 30 Days: 172) (Since Published: 1524) 

Anatara Lifesciences Ltd NEWS: RECENT VISITS (3456)

Research Report

Social Media